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Background: There are some patients with dilated cardiomyopathy (DCM) who do not respond to beta-blocker. Late gadolinium enhancement 
(LGE) by cardiovascular magnetic resonance indicates myocardial fibrosis which may inhibit the beneficial effects of β-blockers on cardiac function. 
However, the association between effect of β-blockers and presence of LGE in DCM patients has not been well evaluated. The purpose of this study 
was to examine the relation of LGE to the cardiac responses of β blockers, and the prognostic values of LGE in DCM patients.
Methods: Consecutive DCM patients (n=66) who underwent cine and LGE MRI were enrolled. Presence or absence of LGE was qualitatively 
determined. Hospitalization for heart failure, ventricular tachycardia and cardiovascular death were evaluated. Cardiac function was compared after 
6 month of βblocker therapy.
Results: Average follow-up time was 20 months (range, 6 to 56 months). In 35 patients without LGE, LV ejection fraction was significantly improved 
by βblocker (0.51+/-12.5SD vs. 0.40+/-0.96, P<0.001), while no improvement was noted in 31 patients with LGE (0.39+/-10.7 vs. 0.40+/-9.2, 
P=0.67). Furthermore, the presence of LGE predicted patients outcome with hazard ratio 9.0 (95% CI 1.2-3.5, P<0.01) in DCM patients treated with 
βblocker.
Conclusions: The presence of LGE is useful in predicting non-responders to beta-blockers and provides the prognostic value in DCM patients 
treated with βblocker.
